Page 9 - Cell Technologies News Today

Chronic health conditions, including heart disease, neurological disorders, cancer, respiratory illnesses, stroke, and cardiovascular disorders, are...

/PRNewswire/ -- NoCell Technologies, a company that develops solutions to mitigate the use of cell phones while behind the wheel of commercial vehicles, and...

The global hybrid grafts market size is estimated to be worth US$ 517.3 million by the end of 2022, and to grow at a CAGR of 5.20% between 2022 and 2032. According to the estimate, the market would be worth US$ 858.7 million by the end of 2032.The hybrid grafts market is set to grow at a fast pace due to increased r...

Colorado startups are using billions in venture capital to help fix health care.

News and analytical articles about Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan.

/PRNewswire/ -- The "Global Cell Dissociation Market by Product (Trypsin, Papain, DNase, Hyaluronidase, Instruments), Tissue Type (Connective Tissue,...

EKPO Fuel Cell Technologies GmbH (EKPO), an entity fully consolidated within the Group of majority shareholder ElringKlinger AG, and operated in partnership with French automotive supplier Plastic Omnium, which holds the remaining ownership interests, secured a contract from a global automotive manufacturer to supply mass-produced bipolar plates for the carmaker’s...

/PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around...

The rapid infuser market is expected to record a 4.5% CAGR from 2023 to 2033, from US$ 1,056.3 million in 2023 to US$ 1,639.8 million in 2033.An Increase in Ambulatory Healthcare Facilities is expected to Create Multiple Market OpportunitiesA rapid infuser is a surgical operation or treatment that includes using a f...

/PRNewswire/ -- Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD® WB...